Scarica l'app Stockscreener
5.95
1.71%
0.10
Dopo l'orario di chiusura:
6.00
0.05
+0.84%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
Where are the Opportunities in (RLAY) - Stock Traders Daily
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat
Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts - Investing.com India
Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts By Investing.com - Investing.com South Africa
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - The Manila Times
Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, - EIN News
Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart
Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses - Yahoo Finance
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Several Relay Therapeutics Insiders Sell Shares Sending Potential Negative Signal - Simply Wall St
Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase - Investing.com Canada
Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase By Investing.com - Investing.com South Africa
Financial Snapshot: Analyzing Relay Therapeutics Inc (RLAY)’s Key Ratio Metrics - The Dwinnex
Relay Therapeutics, Inc. (NASDAQ:RLAY) Short Interest Update - MarketBeat
How did Relay Therapeutics Inc (RLAY) fare last session? - US Post News
Relay Therapeutics (NASDAQ:RLAY) Receives Buy Rating from HC Wainwright - MarketBeat
Relay Therapeutics stock holds price target on FDA approval By Investing.com - Investing.com UK
Relay Therapeutics Inc (RLAY) receives a Buy rating from Jefferies - Knox Daily
(RLAY) Trading Report - Stock Traders Daily
Relay Therapeutics (NASDAQ:RLAY) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Relay Therapeutics Inc: Analyzing RLAY Stock Trends - The InvestChronicle
Relay Therapeutics Inc [NASDAQ: RLAY] Sees Increase in Stock Value - Knox Daily
Millennium Management LLC Purchases 921,271 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Shares Down 4%Here's Why - MarketBeat
Its Stock Has Paid Off Big Time For Relay Therapeutics Inc - SETE News
Thrivent Financial for Lutherans Purchases New Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
Relay Therapeutics Inc (RLAY) is a good investment, but the stock may be overvalued - US Post News
Ratio Analysis: Unpacking Relay Therapeutics Inc (RLAY)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Relay Therapeutics Inc (RLAY) may enjoy gains as insiders got busy in the recent days - Knox Daily
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Marshall Wace LLP Purchases New Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat
Relay Therapeutics to Lay Off 10% of Workforce - BioSpace
Relay Therapeutics cuts 10% of staff after positive trial data - The Business Journals
insider Rahmer Peter sale 245 shares of Relay Therapeutics Inc [RLAY] - Knox Daily
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Relay Therapeutics executive sells shares worth over $2,200 By Investing.com - Investing.com Australia
Stocks of Relay Therapeutics Inc (RLAY) are poised to climb above their peers - SETE News
RLAY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Relay Therapeutics executive sells shares worth over $4,800 - Investing.com India
Biotech layoff tracker: 13 biotechs cut over 1,400 jobs - The Business Journals
Relay Therapeutics executive sells shares worth over $2,200 - Investing.com
Relay Therapeutics executive sells shares worth over $4,800 By Investing.com - Investing.com Australia
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):